Advocacy and activism. Supervised injection facilities
Gold, F.
Canadian Nurse 99(2): 14-18
2003
ISSN/ISBN: 0008-4581 PMID: 12656011 Document Number: 553867
Document emailed within 1 workday
Related Documents
Fedor, M.A. 1992: AIDS: advocacy and activism Nursing and Health Care: Official Publication of the National League for Nursing 13(3): 122-123Fedor, M.A. 1991: AIDS: advocacy and activism Nursing and Health Care: Official Publication of the National League for Nursing 12(5): 233
Fornataro, K. 1993: AIDS: advocacy and activism. Dear President-elect Clinton Nursing and Health Care: Official Publication of the National League for Nursing 14(1): 8-9
Marshall, B.D.L.; Wood, E.; Zhang, R.; Tyndall, M.W.; Montaner, J.S.G.; Kerr, T. 2009: Condom use among injection drug users accessing a supervised injecting facility Sexually Transmitted Infections 85(2): 121-126
Asiimwe, S.; Oloya, J.; Song, X.; Whalen, C.C. 2014: Accuracy of un-supervised versus provider-supervised self-administered HIV testing in Uganda: a randomized implementation trial Aids and Behavior 18(12): 2477-2484
Stringer, E.W. 2003: A study of supervised practice from the perspective of the supervisor and the supervised Insight 28(3): 70-74
Tahan, H.M. 2016: Essentials of Advocacy in Case Management: Part 2: Client Advocacy Model and Case Manager's Advocacy Strategies and Competencies Professional Case Management 21(5): 217-232
Martens, D. 2002: Injection facilities needed to combat infection crisis, AIDS network says Cmaj: Canadian Medical Association Journal 166(11): 1455
Thompson, A.; Kerr, D.; Dowling, J.; Wagner, L. 2012: Advocacy 201: Incorporating advocacy training in health education professional preparation programs Health Education Journal 71(3): 268-277
Thompson, A.; Kerr, D.; Dowling, J.; Wagner, L. 2012: Advocacy 201: Incorporating advocacy training in health education professional preparation programs Health Education Journal 71(3): 268-277
Carson, A.'e.; Hancher-Rauch, H.L.; Gebru, Y. 2018: Building Advocacy Capacity and Skills Through a Statehouse Advocacy Day: Indiana SOPHE Experience Health Promotion Practice 19(6): 803-806
Ruggiano, N.; Taliaferro, J.D.; Dillon, F.R.; Granger, T.; Scher, J. 2014: Networking for Policy Advocacy: Identifying Predictors of Advocacy Success Among Human Service Organizations Human Service Organizations Management, Leadership-Governance 38(1): 89-102
Maycock, B.; Howat, P.; Slevin, T. 2001: A decision-making model for health promotion advocacy: the case for advocacy of drunk driving control measures Promotion and Education (2): 59-64
Luba, M.; Ahmad, R. 2020: 10 minutes with Maureen Luba, Africa Region Advocacy Advisor at AIDS Vaccine Advocacy Coalition, Lilongwe, Malawi BMJ Leader 5(4): 298-299
Luba, M.; Ahmad, R. 2020: 10 minutes with Maureen Luba, Africa Region Advocacy Advisor at AIDS Vaccine Advocacy Coalition, Lilongwe, Malawi BMJ Leader 5(4): 298-299
Carpenter, D. 1992: Professional development module. P9: Advocacy. Part (ii): The 'how' of advocacy Nursing Times 88(27): I-Vii
Antone, N.; Kizub, D.; Gralow, J.; Zujewski, J.A.; Dvaladze, A. 2021: Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings from Women's Empowerment Cancer Advocacy Network (WE CAN) Summits Jco Global Oncology 7: 585-592
Sofia, C.; Portela, F.; Gregório, C.; Rosa, A.; Camacho, E.; Tomé, L.; Ferreira, M.; Andrade, P.; Cabral, P.; Romãozinho, J.; Gouveia, H.; Leitão, M.; Pimenta, I.; Donato, A.; Freitas, D. 2000: Endoscopic injection therapy vs. multipolar electrocoagulation vs. laser vs. injection + octreotide vs. injection + omeprazole in the treatment of bleeding peptic ulcers. A prospective randomized study Hepato-Gastroenterology 47(35): 1332-1336
Hayman, J. 2001: Mortuary facilities. these facilities are inadequate in Australia too Bmj 322(7293): 1066
Brewer, C. 1984: Supervised Antabuse therapy British Journal of Clinical Practice. Supplement 36: 5-11